Fiscal first quarter 2022 revenue of $59.5 million, a 66% increase compared to fiscal first quarter 2021 revenue of $35.9 million Company raises guidance for fiscal year 2022 to $300 million - $305 million, a 78% increase at the midpoint compared to fiscal year 2021 revenue of $170.4 million,

SEATTLE, June 17, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal first quarter 2022 financial results on Thursday, July 8, 2021, after the market closes.

Accolade to begin offering virtual primary care and mental health consultations directly to members. $200bn+ combined total addressable market materially expands opportunity to reinvent healthcare with a focus on improving health outcomes and managing rising costs.

New board directors bring expertise in healthcare services, policy, and human resources SEATTLE , June 3, 2021 /PRNewswire/ -- Accolade (Nasdaq: ACCD), the company reinventing healthcare, today announced a series of changes to its board of directors that will bolster the board with significant

SEATTLE, June 01, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences: The 41st Annual William Blair Growth Stock Conference, including a fireside

SEATTLE, May 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences: The Bank of America 2021 Health Care Conference, including a presentation on

Fiscal fourth quarter 2021 revenue of $59.2 million , a 33% increase compared to fiscal fourth quarter 2020 revenue of $44.4 million  Fiscal year 2021 revenue of $170.4 million , a 29% increase compared to fiscal year 2020 revenue of $132.5 million  Initiates guidance for fiscal year 2022 revenue

Accolade to begin offering virtual primary care and mental health consultations directly to members as a result of the acquisition. $200bn+ combined target addressable market materially expands opportunity to reinvent healthcare with a focus on improving health outcomes and managing rising costs.

SEATTLE, April 19, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced that it will release fiscal fourth

SEATTLE, March 25, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced the pricing of $250 million aggregate principal amount of 0.50% convertible senior notes due 2026 (the “Notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule